Research progress on cellular metabolic reprogramming in skin fibrosis.
10.3724/zdxbyxb-2025-0430
- Author:
Shutong QIAN
1
,
2
;
Siya DAI
3
;
Chunyi GUO
3
;
Jinghong XU
4
Author Information
1. Department of Plastic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. qqqqst97@
2. com.
3. Department of Plastic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
4. Department of Plastic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. doctorxjh@zju.edu.cn.
- Publication Type:English Abstract
- Keywords:
Fatty acid metabolism;
Fibroblasts;
Fibrosis;
Glycolysis;
Metabolic reprogramming;
Review;
Skin diseases;
mTOR/AMPK signal pathway
- MeSH:
Humans;
Fibrosis/metabolism*;
Skin/metabolism*;
Signal Transduction;
Fibroblasts/pathology*;
TOR Serine-Threonine Kinases/metabolism*;
Skin Diseases/pathology*;
Cellular Reprogramming;
Metabolic Reprogramming
- From:
Journal of Zhejiang University. Medical sciences
2025;54(5):592-601
- CountryChina
- Language:Chinese
-
Abstract:
Skin fibrosis is primarily characterized by excessive fibroblasts proliferation and aberrant extracellular matrix accumulation, leading to pathological conditions such as hypertrophic scars, keloids, and systemic sclerosis. This dynamic and complex process involves intricate interactions among various resident skin cells and inflammatory cells, ultimately resulting in extracellular matrix deposition and even invasive growth. The maintenance of cellular phenotypes and functions relies on dynamic metabolic responses, and cellular signal transduction is closely coupled with metabolic processes. Given that the coupling of cell metabolism and signaling in the skin fibrosis microenvironment plays a critical role in inflammatory responses and fibrotic activation, modulation of these metabolic pathways may offer novel therapeutic strategies for inhibiting or even reversing the progression of skin fibrosis. This review systematically summarizes the metabolic characteristics of various cell types involved in skin fibrosis, with a focus on core metabolic reprogramming mechanisms such as hyperactive glycolysis, dysregulated fatty acid metabolism, cellular metabolic dysfunction and dysregulated mTOR/AMPK signaling. Furthermore, potential intervention strategies targeting these metabolic pathways are explored, thereby providing new research perspectives for the treatment of skin fibrosis.
